Auckmed Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.66 M
- Revenue Growth 56.53%
- Profit Growth 1269.48%
- Ebitda 1942.84%
- Net Worth 65.52%
- Total Assets 987.15%
About Auckmed Pharma
Auckmed Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2018 (Six years and two months 21 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.66 M.
Anoop Agarwal and Bhagat Singh serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299UP2018PTC111060
- Company No.
111060
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2018
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Consumer Goods
Who are the key members and board of directors at Auckmed Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhagat Singh  | Director | 03-Mar-2022 | Current |
| Anoop Agarwal | Director | 10-Dec-2018 | Current |
Financial Performance of Auckmed Pharma.
Auckmed Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.53% increase. The company also saw a substantial improvement in profitability, with a 1269.48% increase in profit. The company's net worth Soared by an impressive increase of 65.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Auckmed Pharma?
In 2022, Auckmed Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹3.66 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.37 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Aug 2023 | Hdfc Bank Limited | ₹2.10 M | Open |
| 14 Feb 2023 | Hdfc Bank Limited | ₹1.56 M | Open |
How Many Employees Work at Auckmed Pharma?
Unlock and access historical data on people associated with Auckmed Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auckmed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auckmed Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
